160 related articles for article (PubMed ID: 31965262)
1. Pulmonary aspergillosis as a late complication after surgery for locally advanced non-small cell lung cancer treated with induction chemoradiotherapy.
Sugimoto S; Soh J; Suzawa K; Miyoshi K; Otani S; Yamamoto H; Okazaki M; Yamane M; Oto T; Kanazawa S; Kiura K; Toyooka S
Surg Today; 2020 Aug; 50(8):863-871. PubMed ID: 31965262
[TBL] [Abstract][Full Text] [Related]
2. Chronic Lung Injury After Trimodality Therapy for Locally Advanced Non-Small Cell Lung Cancer.
Soh J; Sugimoto S; Namba K; Miura A; Shiotani T; Yamamoto H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Katsui K; Yamane M; Kiura K; Kanazawa S; Toyooka S
Ann Thorac Surg; 2021 Jul; 112(1):279-288. PubMed ID: 33068542
[TBL] [Abstract][Full Text] [Related]
3. Chronic pulmonary aspergillosis as a sequel to lobectomy for lung cancer.
Tamura A; Suzuki J; Fukami T; Matsui H; Akagawa S; Ohta K; Hebisawa A; Takahashi F
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):650-6. PubMed ID: 26323287
[TBL] [Abstract][Full Text] [Related]
4. Preoperative contralateral lung radiation dose is associated with postoperative pulmonary toxicity in patients with locally advanced non-small cell lung cancer treated with trimodality therapy.
Guo W; Hui X; Alfaifi S; Anderson L; Robertson S; Hales R; Hu C; McNutt T; Broderick S; Naidoo J; Battafarano R; Yang S; Voong KR
Pract Radiat Oncol; 2018; 8(4):e239-e248. PubMed ID: 29960625
[TBL] [Abstract][Full Text] [Related]
5. Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?
Yamaguchi M; Shimamatsu S; Edagawa M; Hirai F; Toyozawa R; Nosaki K; Seto T; Takenoyama M; Ichinose Y
Surg Today; 2019 Mar; 49(3):197-205. PubMed ID: 30610361
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of patients with recurrent non-small cell lung cancer after trimodality therapy.
Suzawa K; Soh J; Takahashi Y; Sato H; Shien K; Yamamoto H; Kanazawa S; Kiura K; Miyoshi S; Toyooka S
Surg Today; 2019 Jul; 49(7):601-609. PubMed ID: 30734881
[TBL] [Abstract][Full Text] [Related]
7. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
8. Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion?
Sato H; Soh J; Hotta K; Katsui K; Kanazawa S; Kiura K; Toyooka S
Ann Thorac Cardiovasc Surg; 2018 Jun; 24(3):131-138. PubMed ID: 29681596
[TBL] [Abstract][Full Text] [Related]
9. Post-treatment mortality after definitive chemoradiotherapy versus trimodality therapy for locally advanced non-small cell lung cancer.
Haque W; Verma V; Butler EB; Teh BS; Rusthoven CG
Lung Cancer; 2019 Jan; 127():76-83. PubMed ID: 30642556
[TBL] [Abstract][Full Text] [Related]
10. Induction chemoradiotherapy followed by surgery for locally advanced non-small cell lung cancer.
Kusumoto S; Hirose T; Fukayama M; Kataoka D; Hamada K; Sugiyama T; Shirai T; Yamaoka T; Okuda K; Ohnishi T; Ohmori T; Kadokura M; Adachi M
Oncol Rep; 2009 Nov; 22(5):1157-62. PubMed ID: 19787234
[TBL] [Abstract][Full Text] [Related]
11. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
12. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer.
Gao SJ; Corso CD; Wang EH; Blasberg JD; Detterbeck FC; Boffa DJ; Decker RH; Kim AW
J Thorac Oncol; 2017 Feb; 12(2):314-322. PubMed ID: 27720827
[TBL] [Abstract][Full Text] [Related]
13. Density of tumor-infiltrating FOXP3+ T cells as a response marker for induction chemoradiotherapy and a potential prognostic factor in patients treated with trimodality therapy for locally advanced non-small cell lung cancer.
Tao H; Shien K; Soh J; Matsuda E; Toyooka S; Okabe K; Miyoshi S
Ann Thorac Cardiovasc Surg; 2014; 20(6):980-6. PubMed ID: 24583705
[TBL] [Abstract][Full Text] [Related]
14. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
[TBL] [Abstract][Full Text] [Related]
15. Morbidity and mortality after major pulmonary resections in patients with locally advanced stage IIIA non-small cell lung carcinoma who underwent induction therapy.
Peer M; Stav D; Cyjon A; Sandbank J; Vasserman M; Haitov Z; Sasson L; Schreiber L; Ezri T; Priel IE; Hayat H
Heart Lung Circ; 2015 Jan; 24(1):69-76. PubMed ID: 25086910
[TBL] [Abstract][Full Text] [Related]
16. Preoperative concurrent chemoradiotherapy followed by extrapleural pneumonectomy for patients with non-small cell lung cancer with malignant pleural effusion and/or pleural nodules: Ten-year results of a prematurely terminated single institute phase II trial.
Yamaguchi M; Ichinose Y; Shimamatsu S; Yoshida T; Toyokawa G; Nosaki K; Hirai F; Seto T; Takenoyama M
Surg Oncol; 2015 Jun; 24(2):78-83. PubMed ID: 25818753
[TBL] [Abstract][Full Text] [Related]
17. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.
Weder W; Collaud S; Eberhardt WE; Hillinger S; Welter S; Stahel R; Stamatis G
J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1424-30. PubMed ID: 20416887
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.
Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
Thorac Cardiovasc Surg; 2018 Mar; 66(2):135-141. PubMed ID: 28992654
[TBL] [Abstract][Full Text] [Related]
19. Prognostic nutrition index affects the prognosis of patients undergoing trimodality therapy for locally advanced non-small cell lung cancer.
Soh J; Suzawa K; Shien K; Otani S; Yamamoto H; Okazaki M; Sugimoto S; Katsui K; Yamane M; Kiura K; Kanazawa S; Toyooka S
Surg Today; 2020 Dec; 50(12):1610-1618. PubMed ID: 32914233
[TBL] [Abstract][Full Text] [Related]
20. Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity.
Aravot D; Barac YD; Krutzwald-Josefson E; Allen AM; Flex D; Peled N; Kramer MR; Peysakhovich Y; Saute M
J Cardiothorac Surg; 2019 Jan; 14(1):7. PubMed ID: 30626407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
